• [[Translated article]]Satisfactory Response to Pulsed Dye Laser Treatment of Facial Erythema in a Patient with Amyopathic Dermatomyositis
• [Translated article] Satisfactory Response to Pulsed Dye Laser Treatment of Facial Erythema in a Patient with Amyopathic Dermatomyositis
• "Amyopathic" MDA5-positive dermatomyositis with severe lung involvement presenting with net myositic morphological features - insights from an autopsy study
• A case of amyopathic dermatomyositis with flagellate dermatitis
• A case of anti-SAE antibody-positive clinically amyopathic dermatomyositis complicated by advanced gastric cancer and interstitial lung disease
• A case of refractory amyopathic dermatomyositis successfully treated with upadacitinib
• Amyopathic dermatomyositis may be on the spectrum of autoinflammatory disease: A clinical review
• Amyopathic Dermatomyositis Presenting with Digital Ulcerations: Case Report and Literature Review
• Amyopathic dermatomyositis with TIF1? positivity treated with IVIG
• An autopsy case of anti-MDA5 antibody-positive amyopathic dermatomyositis with an initial manifestation of panniculitis on the left upper arm
• Analytic and Clinical Validity of Myositis-Specific Antibodies by Line-Blot Immunoassay Is Essential
• Anti-MDA5 antibody-associated clinically amyopathic dermatomyositis diagnosed after the onset of pulmonary hypertension
• Anti-MDA5 Antibody-Positive Clinically Amyopathic Dermatomyositis Associated With Multiple Heterologous Carcinomas: A Case Report
• Anti-MDA5 Antibody-positive Clinically Amyopathic Dermatomyositis with Rapidly Progressing Interstitial Lung Disease Successfully Treated by Initiation of Combined Immunosuppressive Therapy Plus Plasma Exchange and Subsequently Switching Tacrolimus to Tof
• Anti-melanoma Differentiation-Associated Gene 5 (Anti-MDA5) Dermatomyositis-Associated Interstitial Lung Disease Complicated by Pneumomediastinum: A Case Report and Literature Review
• Anti-melanoma differentiation-associated gene 5 and anti-Ro52 antibody-dual positive dermatomyositis accompanied by rapidly lung disease: Three case reports
• Anti-nuclear matrix protein 2 antibody-positive amyopathic dermatomyositis presenting in a patient with prostate cancer: A case report
• Anti-Ro52/Anti-nuclear Matrix Protein 2 Positive Clinically Amyopathic Dermatomyositis Presented Only With Interstitial Lung Disease
• Antibodies against Serum Anti-Melanoma Differentiation-Associated Gene 5 in Rheumatoid Arthritis Patients with Chronic Lung Diseases
• Association between periungual changes and myositis-specific autoantibodies in patients with idiopathic inflammatory myopathies: A retrospective cohort study
• Asymptomatic and slowly progressive anti-MDA5 ILD: A report of three cases deviating from a notoriously rapidly progressive ILD
• Authors' reply to "a case of juvenile amyopathic dermatomyositis with anti-transcription intermediary factor 1-α antibody showing negative anti-TIF1-γ ELISA results: Comment on the article by Mizumaki et al."
• Autoimmune pulmonary alveolar proteinosis during the treatment of nonspecific interstitial pneumonia complicated by clinically amyopathic dermatomyositis: A case report
• Case report: "Fur stole and turtleneck" and "halter-back" signs: an expanded wardrobe for dermatomyositis
• Case report: Checkpoint inhibitor pneumonitis with positive anti-melanoma differentiation-associated gene 5 antibodies in a patient with lung cancer
• Clinical characteristics and prognostic factors of patients with anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis associated interstitial lung disease
• Clinical Characteristics and Prognostic Value of Ro52/SSA Antibodies in Idiopathic Inflammatory Myopathies
• Clinical characteristics and symptom progression of dermatomyositis subtypes: A retrospective analysis of a prospective database
• Clinical Characteristics of Dermatomyositis with Interstitial Lung Disease: A Retrospective Case-Control Study
• Clinical importance of anti-Ro52 antibody for polymyositis and dermatomyositis
• Clinical phenotyping in patients with anti-synthetase antibodies using cluster analysis
• Clinical, histologic and prognostic features of clinically amyopathic dermatomyositis
• Clinically amyopathic dermatomyositis : a rare entity associated with acute and severe interstitial lung disease
• Clinically amyopathic dermatomyositis associated with cutaneous ulcerations: a case-based review
• Clinically amyopathic dermatomyositis: Clinical, laboratory, and histopathological features
• Clinically Amyopathic Juvenile Dermatomyositis
• Coexistence of anti-KS and anti-TIF1-gamma antibodies in clinically amyopathic dermatomyositis presenting with rapid progression of interstitial lung disease
• Coexistent Relapsing Polychondritis and Clinically Amyopathic Dermatomyositis: A Rare Association of Autoimmune Disorders
• Comparison of characteristics and anti-MDA5 antibody distribution and effect between clinically amyopathic dermatomyositis and classic dermatomyositis: a retrospective case-control study
• Comparison of clinical and laboratory features and treatment responses in patients with clinically amyopathic juvenile dermatomyositis and classical juvenile dermatomyositis
• Dermatomyositis
• Dermatomyositis With Dual Positive Anti-melanoma Differentiation-Associated Gene 5 and Anti-Sjogren Syndrome-Related Antigen 52 kD Antibodies: A Case Report and Literature Review on Clinical Characteristics
• Diagnosis of neuropsychiatry disorder in patients with anti-MDA5 antibody dermatomyositis: A case report
• Differences in the autoantibody phenotypes and long-term outcomes between juvenile- and adult-idiopathic inflammatory myopathies
• Effect of Therapeutic Plasma Exchange on Itraconazole Pharmacokinetics: A Case Study
• Effectiveness and safety of plasma exchange for anti-MDA5 antibody-positive clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease refractory to intensive immune suppression therapy: A case series
• Erythrodermic dermatomyositis with anti-TIF1-γ antibodies
• Extended-Release Tofacitinib Therapy for a MDA5 Antibody-Positive Amyopathic Dermatomyositis Patient with Early-Stage Interstitial Lung Disease
• Idiopathic Inflammatory Myopathies
• Idiopathic inflammatory myopathies linked to vaccination against SARS-CoV-2: a systematic review
• IFN-γ: An overlooked cytokine in dermatomyositis with anti-MDA5 antibodies
• Intramuscular lesions in musculoskeletal MRI as a favourable prognostic sign in patients with anti-MDA5 antibody-positive dermatomyositis
• Juvenile Dermatomyositis Presenting As Generalized Poikiloderma: A Case Report
• Lung infection or inflammation-a puzzling case of MDA-5 associated juvenile dermatomyositis
• Patient-reported quality of life and working status outcomes in ambulatory patients with idiopathic inflammatory myopathy
• Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review
• Pitfalls in the Diagnosis and Management of an Unusual Presentation of Clinically Amyopathic Dermatomyositis: A Case Report Written With the Assistance of ChatGPT
• Prognostic analysis of MDA5-associated clinically amyopathic dermatomyositis with interstitial lung disease
• Racial Disparities in Diagnosis and Treatment of Patients With Dermatomyositis of Different Skin Tones
• Rapidly progressive interstitial lung disease in clinically amyopathic dermatomyositis triggered by a 23-valent pneumococcal polysaccharide vaccine
• Rapidly Progressive Interstitial Lung Disease With Pneumothorax and Pneumomediastinum Secondary to Amyopathic Dermatomyositis
• Rapidly progressive interstitial lung disease with positive anti-MDA5 antibody as an immune-related complication of nivolumab: A case report
• Rheumatoid meningitis in a patient with overlap syndrome: The usefulness of anti-citrullinated peptide antibodies determination in CSF
• Soluble CD206 levels correlate with disease deterioration and predict prognosis of anti-MDA5 antibody-positive dermatomyositis related interstitial lung disease
• Successful Treatment of Ultrasound-confirmed Synovitis in Anti-MDA5 Antibody-positive Clinically Amyopathic Dermatomyositis with Corticosteroid Therapy
• The clinical relevance of WDFY4 in autoimmune diseases in diverse ancestral populations
• The lung as a site for the generation of anti-MDA5 antibody in clinically amyopathic dermatomyositis
• This Month in JAAD: July 2024
• Tofacitinib therapy in refractory inflammatory myositis: a retrospective cohort study of 41 patients
• Treatment alternatives for amyopathic MDA5-positive dermatomyositis
• Treatment strategies in MDA5-positive clinically amyopathic dermatomyositis: a single-center retrospective analysis
• Two challenging cases of anti-MDA-5 dermatomyositis with rapidly progressive interstitial lung disease
• Ulcerative rash in a patient with anti-MDA5 antibody-associated clinically amyopathic dermatomyositis
• Upregulation of the CD155-CD226 Axis Is Associated With Muscle Inflammation and Disease Severity in Idiopathic Inflammatory Myopathies
• When a Painful Rash Keeps Recurring: A Case of Seronegative Amyopathic Dermatomyositis Without Neurological Sequelae